These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38619281)

  • 1. RANKL signaling drives skeletal muscle into the oxidative profile.
    Cavalcanti de Araújo PH; Cezine MER; Vulczak A; Vieira LC; Matsuo FS; Remoto JM; Santos ADR; Miyabara EH; Alberici LC; Osako MK
    J Bone Miner Res; 2024 Jul; 39(6):753-764. PubMed ID: 38619281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
    Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice.
    Hamoudi D; Bouredji Z; Marcadet L; Yagita H; Landry LB; Argaw A; Frenette J
    Hum Mol Genet; 2020 Feb; 29(3):483-494. PubMed ID: 31943048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL induces beige adipocyte differentiation in preadipocytes.
    Matsuo FS; Cavalcanti de Araújo PH; Mota RF; Carvalho AJR; Santos de Queiroz M; Baldo de Almeida B; Ferreira KCOS; Metzner RJM; Ferrari GD; Alberici LC; Osako MK
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E866-E877. PubMed ID: 32315212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.
    Chen T; Feng X
    Assay Drug Dev Technol; 2006 Aug; 4(4):473-82. PubMed ID: 16945019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
    Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
    Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
    Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.
    Deligiorgi MV; Panayiotidis MI; Griniatsos J; Trafalis DT
    Clin Exp Metastasis; 2020 Feb; 37(1):13-30. PubMed ID: 31578655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.
    Warren JT; Zou W; Decker CE; Rohatgi N; Nelson CA; Fremont DH; Teitelbaum SL
    J Cell Biochem; 2015 Nov; 116(11):2476-83. PubMed ID: 25864714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway.
    Zhao Y; Wang HL; Li TT; Yang F; Tzeng CM
    Drug Des Devel Ther; 2020; 14():195-206. PubMed ID: 32021104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.
    Shimamura M; Nakagami H; Osako MK; Kurinami H; Koriyama H; Zhengda P; Tomioka H; Tenma A; Wakayama K; Morishita R
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8191-6. PubMed ID: 24847069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.
    Zeng R; Faccio R; Novack DV
    J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.
    Hofbauer LC; Heufelder AE
    J Mol Med (Berl); 2001 Jun; 79(5-6):243-53. PubMed ID: 11485016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
    Tat SK; Padrines M; Theoleyre S; Couillaud-Battaglia S; Heymann D; Redini F; Fortun Y
    Bone; 2006 Oct; 39(4):706-15. PubMed ID: 16750945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling.
    Jiang Y; Zhang Y; Chen W; Liu C; Li X; Sun D; Liu Z; Xu Y; Mao X; Guo Q; Lin N
    J Transl Med; 2014 Nov; 12():334. PubMed ID: 25471933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.